You have 9 free searches left this month | for more free features.

Cancer, Covid-19, Vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

Active, not recruiting
  • COVID-19 Infection
  • Malignant Solid Neoplasm
  • Biospecimen Collection
  • Electronic Health Record Review
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 6, 2023

Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,

Recruiting
  • Health Behavior
  • +6 more
  • Financial incentive for colorectal cancer screening
  • +2 more
  • New Orleans, Louisiana
    Tulane University School of Medicine
Nov 13, 2023

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients

Active, not recruiting
  • Cancer
  • Covid19
  • COVID-19 vaccine
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 9, 2022

Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)

Completed
  • Covid19
  • +3 more
  • SARS-COV2 Pfizer Vaccine
  • Tucson, Arizona
    University of Arizona
May 19, 2022

SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology

Active, not recruiting
  • Covid19
  • Cancer
  • Blood Sample
  • Rochester, New York
    University of Rochester
Sep 6, 2022

COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among

Active, not recruiting
  • Covid19
  • SARS-CoV2 Infection
  • mRNA-1273
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2022

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

Host Immune Response to Novel RNA COVID-19 Vaccination

Recruiting
  • COVID-19 Vaccine
  • Cancer
  • COVID-19 Vaccine
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
Apr 22, 2022

To Assess Immunogenicity of Coronavirus Disease 2019 Vaccine in

Recruiting
  • Breast Cancer
  • +2 more
  • COVID-19 Vaccine
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Mar 31, 2022

Coronavirus Disease 2019 Vaccination in Cancer Patients

Recruiting
  • Malignancies Multiple
  • COVID-19 vaccine hesitancy and acceptance survey
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Feb 28, 2022

COVID-19, Cancer Trial in Ratchathewi (CoronaVac vaccine)

Completed
  • COVID-19
  • Cancer
  • CoronaVac vaccine
  • Ratchathewi, Bangkok, Thailand
    National Cancer Institute
Apr 9, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Cancer Trial in Amsterdam, Groningen, Rotterdam (mRNA-1273 SARS-CoV-2 vaccine from Moderna)

Active, not recruiting
  • Cancer
  • mRNA-1273 SARS-CoV-2 vaccine from Moderna
  • Amsterdam, Netherlands
  • +2 more
Mar 1, 2022

Covid19, Cancer Trial in Istanbul (COVID-19 antibody test)

Completed
  • Covid19
  • Cancer
  • COVID-19 antibody test
  • Istanbul, Fatih, Turkey
  • +4 more
Aug 1, 2021

COVID-19 Infection Trial in Duarte (Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1)

Recruiting
  • COVID-19 Infection
  • Placebo Administration
  • Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Dec 15, 2021

COVID-19 Vaccine in Immunotherapy and Non-IO Treated Cancer

Completed
  • COVID-19
  • Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    Oct 1, 2021

    COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

    Recruiting
    • COVID-19 Infection
    • +4 more
    • COVID-19 Vaccine
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 2, 2021

    Patients With Cancer, Vaccine Reaction, COVID-19 Trial in Beijing (Coronavirus vaccination)

    Recruiting
    • Patients With Cancer
    • +2 more
    • Coronavirus vaccination
    • Beijing, China
      302 Hospital
    Apr 11, 2022

    mRNA Covid-19 Vaccines on Cancer Patients:Observational Study.

    Recruiting
    • Cancer
    • +2 more
    • Serum collection, adverse events collection
    • Cremona, Lombardia, Italy
      UO Oncologia, ASST di Cremona
    Jul 22, 2021

    Third Dose of SARS-CoV-2 Vaccine inCohort of Cancer Patients on

    Recruiting
    • Sars-CoV-2 Infection
    • Three doses of BNT162b2 (observational)
    • Two doses of Coronavac and one dose BNT162b2 (observational)
    • Santiago, Chile
      Red de Salud UC Christus
    Feb 1, 2022

    COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),

    Not yet recruiting
    • COVID-19
    • +4 more
    • Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
    • Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
    • (no location specified)
    Sep 29, 2023

    Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,

    Active, not recruiting
    • Coronavirus
    • +2 more
    • BCG Vaccine
    • Placebo Vaccine
    • Los Angeles, California
    • +5 more
    Oct 18, 2022

    Cancer Trial in Belgium (Blood sampling)

    Recruiting
    • Cancer
    • Blood sampling
    • Edegem, Antwerp, Belgium
    • +7 more
    Aug 31, 2021

    BNT162b2 Messenger Ribonucleic Acid Covid-19 Vaccine in Cancer

    Recruiting
    • Neoplasms
    • Cancer, Treatment-Related
    • BNT162b2 mRNA Covid-19 Vaccine
    • Genova, Italy
      E.O. Ospedali Galliera
    Jun 18, 2021